NYSE:HIMS • US4330001060
The current stock price of HIMS is 16.27 USD. In the past month the price decreased by -48.15%. In the past year, price decreased by -66.98%.
ChartMill assigns a fundamental rating of 5 / 10 to HIMS. HIMS has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months HIMS reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS increased by 22.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.05% | ||
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| Debt/Equity | 1.67 |
22 analysts have analysed HIMS and the average price target is 43.45 USD. This implies a price increase of 167.03% is expected in the next year compared to the current price of 16.27.
For the next year, analysts expect an EPS growth of -11.37% and a revenue growth 60.27% for HIMS
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.8 | 99.269B | ||
| CI | THE CIGNA GROUP | 9.3 | 76.59B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 94.09 | 23.249B | ||
| LH | LABCORP HOLDINGS INC | 15.33 | 22.936B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.55 | 22.859B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.8B | ||
| DVA | DAVITA INC | 11.37 | 10.311B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 28.07 | 6.936B | ||
| CHE | CHEMED CORP | 18.43 | 6.699B | ||
| OPCH | OPTION CARE HEALTH INC | 18.48 | 5.594B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,637 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
HIMS & HERS HEALTH INC
2269 Chestnut St, #523
San Francisco CALIFORNIA 94123 US
CEO: Andrew Dudum
Employees: 1637
Phone: 18003166660
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,637 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
The current stock price of HIMS is 16.27 USD. The price decreased by -0.18% in the last trading session.
HIMS does not pay a dividend.
HIMS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for HIMS & HERS HEALTH INC (HIMS) is 30.13. This is based on the reported non-GAAP earnings per share of 0.54 and the current share price of 16.27 USD.
HIMS & HERS HEALTH INC (HIMS) will report earnings on 2026-02-23, after the market close.